Fangchi Shao, Jiumei Hu, Pengfei Zhang, Patarajarin Akarapipad, Joon Soo Park, Hanran Lei, Kuangwen Hsieh, Tza-Huei Wang
{"title":"通过磁性接近延伸和检测增强基于 CRISPR/Cas 的免疫测定","authors":"Fangchi Shao, Jiumei Hu, Pengfei Zhang, Patarajarin Akarapipad, Joon Soo Park, Hanran Lei, Kuangwen Hsieh, Tza-Huei Wang","doi":"10.1101/2024.09.06.24313206","DOIUrl":null,"url":null,"abstract":"Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.","PeriodicalId":501023,"journal":{"name":"medRxiv - Primary Care Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection\",\"authors\":\"Fangchi Shao, Jiumei Hu, Pengfei Zhang, Patarajarin Akarapipad, Joon Soo Park, Hanran Lei, Kuangwen Hsieh, Tza-Huei Wang\",\"doi\":\"10.1101/2024.09.06.24313206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.\",\"PeriodicalId\":501023,\"journal\":{\"name\":\"medRxiv - Primary Care Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Primary Care Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.09.06.24313206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Primary Care Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.06.24313206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
成簇的规则间隔短回文重复序列(CRISPR)/Cas 相关系统最近已成为开发下一代分子诊断的焦点,尤其是在核酸检测方面。然而,蛋白质的检测在生物学、医学和食品工业的各种应用中同样至关重要,尤其是在诊断和预后癌症、老年痴呆症和心血管疾病等方面。尽管最近人们努力将 CRISPR/Cas 系统用于免疫测定的蛋白质检测,但这些方法通常只能达到飞摩尔到皮摩尔范围的灵敏度,这突出表明需要增强检测能力。为了解决这个问题,我们开发了 CRISPR-AMPED,这是一种创新的基于 CRISPR/Cas 的免疫测定方法,通过磁性接近延伸和检测得到了增强。这种方法结合了磁珠近距离延伸检测(PEA),可将蛋白质转化为 DNA 条形码进行定量,并通过有效的清洗步骤将非特异性结合和杂交降至最低,从而降低背景噪声并提高检测灵敏度。然后,利用重组酶聚合酶扩增(RPA)和 CRISPR/Cas12a 系统,通过等温核酸扩增检测(NAAT)来检测生成的 DNA 条形码,从而取代传统的 PCR。这种整合无需热循环和笨重的设备,缩短了扩增时间,并可同时进行目标和信号扩增,从而大大提高了检测灵敏度。CRISPR-AMPED 实现了阿托摩尔级的灵敏度,比 ELISA 高出三个数量级以上,优于现有的基于 CRISPR/Cas 的检测系统。此外,我们基于智能手机的检测设备展示了在护理点应用的潜力,数字格式扩大了动态范围并提高了定量精度。我们相信,CRISPR-AMPED 代表了蛋白质检测领域的一大进步。
Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.